Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 1. Zelnicek T D, Miller J L, Vijayarajah S, Johnson P N. A Case Series and Review of Literature Describing the Use of Midodrine for Vasopressor Effects in Infants With Congenital Heart Disease. Hospital Pharmacy. 2024
2. Flanagan T, Mercer K, Johnson P N, Miller J L, Perrine J. Ketamine Use in Adult and Pediatric Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review. Journal of Pharmacy Practice. 2023
3. Johnson P N, Parman A, Miller J L. Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023
4. Casten M, Miller J L, Neely S, Harkin M, Johnson P N. Variability in opioid conversion calculators in critically ill children transitioned from fentanyl to hydromorphone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023
5. Chang E, Johnson P N, Medina M, Dennis V C, Neely S, Miller J L. Sculpting a teaching and learning curriculum to better meet the career needs of postgraduate year 1 and 2 pharmacy residents. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023; 80 : 765-771
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 21. University of Oklahoma College of Medicine, Department of Pediatrics. Best Trainee Research Award (Served as resident mentor). Date: 2015.
22. Pediatric Pharmacy Advocacy Group. Special Recognition Award. Date: 2015.
23. ACCP Pediatric Practice and Research Network. Travel Award (Served as student mentor). Date: 2014.
24. Pediatric Pharmacy Advocacy Group. Original Research Award. Date: 2014.
25. Pediatric Pharmacy Advocacy Group. Presidential Citation. Date: 2013.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results